Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia

Leukemia

Volumn 24, Issue 1, 2010, Pages 239-242

  Jotta, P Y ^a   Ganazza, M A ^a   Silva, A ^b   Viana, M B ^c   Da Silva, M J ^d   Zambaldi, L J G ^a   Barata, J T ^b   Brandalise, S R ^a,d   Yunes, J A ^a  

^a CENTRO INFANTIL BOLDRINI   (Brazil)

^b UNIVERSITY OF LISBON   (Portugal)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; BONE MARROW BIOPSY; CANCER SURVIVAL; CHILD; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PRIORITY JOURNAL; PROGNOSIS;

EID: 74249086850     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.209     Document Type: Letter

References (8)

1. Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M et al. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008; 118: 3762-3774.
2. Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447: 966-971.
3. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203-1210.
4. Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y et al. High frequency of PTEN, PI3K and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009; 114: 647-650.
5. Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-{beta} and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009; 114: 1053-1062.
6. Larson GA, Chen Q, Kugel DS, Ge Y, Lafiura K, Haska CL et al. The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia 2009; 23: 1417-1425.
7. Cortez MA, Scrideli CA, Yunes JA, Valera ET, Toledo S, Pavoni-Ferreira PCB et al. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death. Pediatric Blood Câncer 2009; 53: 996-1004.
8. Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc Natl Acad Sci USA 1999; 96: 10182-10187.